Mallinckrodt Pharmaceuticals (Adrabetadex) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Mallinckrodt Pharmaceuticals (Adrabetadex) General Information

Description

Adrabetadex (also known as VTS-270) drug of Mallinckrodt Pharmaceuticals. The drug is in development and intended to be used for the treatment of Niemann-Pick Type C1 disease (NPC1).

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Dublin
  • Ireland
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Acquirer
Corporate Office
  • Dublin
  • Ireland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mallinckrodt Pharmaceuticals (Adrabetadex) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Mallinckrodt Pharmaceuticals (Adrabetadex)‘s full profile, request access.

Request a free trial

Mallinckrodt Pharmaceuticals (Adrabetadex) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Mallinckrodt Pharmaceuticals (Adrabetadex)‘s full profile, request access.

Request a free trial

Mallinckrodt Pharmaceuticals (Adrabetadex) FAQs

  • Where is Mallinckrodt Pharmaceuticals (Adrabetadex) headquartered?

    Mallinckrodt Pharmaceuticals (Adrabetadex) is headquartered in Dublin, Ireland.

  • What industry is Mallinckrodt Pharmaceuticals (Adrabetadex) in?

    Mallinckrodt Pharmaceuticals (Adrabetadex)’s primary industry is Buildings and Property.

  • Is Mallinckrodt Pharmaceuticals (Adrabetadex) a private or public company?

    Mallinckrodt Pharmaceuticals (Adrabetadex) is a Private company.

  • What is Mallinckrodt Pharmaceuticals (Adrabetadex)’s current revenue?

    The current revenue for Mallinckrodt Pharmaceuticals (Adrabetadex) is .

  • Who are Mallinckrodt Pharmaceuticals (Adrabetadex)’s investors?

    Mallinckrodt Pharmaceuticals has invested in Mallinckrodt Pharmaceuticals (Adrabetadex).

  • When was Mallinckrodt Pharmaceuticals (Adrabetadex) acquired?

    Mallinckrodt Pharmaceuticals (Adrabetadex) was acquired on 01-Jul-2021.

  • Who acquired Mallinckrodt Pharmaceuticals (Adrabetadex)?

    Mallinckrodt Pharmaceuticals (Adrabetadex) was acquired by Mandos Health.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process